Target intelligence / Profile preview

MT-ND3 pseudogene 22 (MTND3P22)

Target
MTND3P22
Molecular classification
Other (Pseudogene)
01

Overview

MT-ND3 pseudogene 22 (MTND3P22) is a nuclear-encoded pseudogene related to the mitochondrial gene MT-ND3, which codes for a component of mitochondrial complex I[2]. It is also known as mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3 pseudogene 22. As a pseudogene, MTND3P22 does not produce a functional protein and does not participate in any known biological activity, disease, or drug interactions. Pseudogenes are typically considered non-functional DNA sequences resulting from duplication or retrotransposition events and generally do not encode proteins or have a direct therapeutic relevance[2]. This entry is a pseudogene, not an active protein-coding gene, enzyme, receptor, or therapeutic target[2]. There is no evidence that MTND3P22 has a functional or pathological role, nor that it interacts with any drugs, serves as a biomarker, or is a safety concern. Information about the active MT-ND3 gene is available and related to mitochondrial disease, but MTND3P22 itself is non-functional[2][1]. If a therapeutic or diagnostic focus is intended, MTND3P22 is not an appropriate target.

Other names
MTND3P22mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3 pseudogene 22

Beyond the preview

Go deeper on MT-ND3 pseudogene 22 (MTND3P22).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-ND3 pseudogene 22 (MTND3P22).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call